Clinisciences > NUAK2 Human shRNA Lentiviral Particle (Locus ID 81788)
NUAK2 Human shRNA Lentiviral Particle (Locus ID 81788)
Referentie TL320737V
Formaat : 500uleach
NUAK2 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control) locus_ID:81788
- Home
- Products
- RNAi
- shRNA Lentiviral Particles
- NUAK2 Human shRNA Lentiviral Particle (Locus ID 81788)
NUAK2 Human shRNA Lentiviral Particle (Locus ID 81788)
SKU
TL320737V
NUAK2 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.
- Lenti
Ready-to-use Lentiviral Particles
Click here to learn more.
5 Weeks*
Size
Frequently Bought Together (3)
TA302109 | Rabbit Polyclonal Antibody against NUAK2 (N-term) | 400 ul | ||
TR30038 | One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA | 96 reactions | ||
TR30021V | Control Lenti particles, Scrambled shRNA, Expressing GFP and Puro, >1x10^7 TU/ml, 0.5 ml | 1 x 10^7 TU/ml, 500 ul |
Other products for "NUAK2"
- cDNA Clones
- Lentiviral
- CRISPR
- RNAi
- Proteins
- Antibodies
Product Data | |
Locus ID | 81788 |
---|---|
Synonyms | SNARK |
Vector | pGFP-C-shLenti |
Format | Lentiviral particles |
Components | NUAK2 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml. |
RefSeq | NM_030952, NM_030952.1, NM_030952.2, BC017306, BC017306.2 |
UniProt ID | Q9H093 |
Summary | Stress-activated kinase involved in tolerance to glucose starvation. Induces cell-cell detachment by increasing F-actin conversion to G-actin. Expression is induced by CD95 or TNF-alpha, via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is required for the increased motility and invasiveness of CD95-activated tumor cells. Able to phosphorylate 'Ser-464' of LATS1.[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact tech@clinisciences.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at tech@clinisciences.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Write Your Own Review
Product Manuals |
|
FAQs |
|
SDS |
RNAi Resources |
|
Related Products
Check items to add to the cart or
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.